Search

Peter Mac’s Associate Professor Michael Dickinson has presented new data from a trial of the investigational blood cancer drug Glofitamab, at the annual meeting of the American Society of Clinical Oncology (ASCO)... Read more

Last week, Canthera Discovery won the Cooperative Research Australia (CRA) Award for Research Commercialisation at its Innovation Awards. Peter Mac is one of the founding members of the... Read more

Peter Mac's Associate Professor Jane Oliaro and Professor Ricky Johnstone have been awarded funding for two different blood cancer research projects. Associate Professor Oliaro will use a three year grant to make CAR T-cell... Read more

Almost $1.8 million has been awarded to five Peter Mac Researchers by the Cancer Council Victoria (CCV) to improve a range of different cancer treatments.  Grants-in-Aid are awarded each year to fund high quality research... Read more

Some women who undergo preventative surgery to avoid reproductive cancers go on to develop incurable abdominal cancer. A clinical trial, involving Peter Mac, is testing a way to possibly prevent this. Women with a BRCA1 or... Read more

A new drug is showing potent results in hard-to-treat blood cancers and was able to trigger a complete response – meaning the cancer became undetectable – for more than a third of patients. All patients in the Phase I /... Read more